SWOG S1815

Primary Category:

Treatment Protocols

Disease Category:

Cholangiocarcinoma, Gallbladder, Gastrointestinal


Temporarily Closed

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Eligible for screening study DCP 001


Effective, March 5th, 2020, study S1815 will be temporarily closed to accrual of new patients.  Accrual will re-open after the revision for the accrual goal increase is approved and distributed.